Detlev Biniszkiewicz News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Detlev Biniszkiewicz. Real-time updates on events, politics, business and more.

Latest Updates of Viva's Portfolio Companies

December 4, 2023

/PRNewswire/ -- Even with the ever-changing situation, technological innovation is still the most critical component for biopharmaceutical companies long-term...

United States Al Iskandariyah San Diego South San Francisco Viva Bioinnovator Prnewswire Triumvira Immunologics

Source: prnewswire.com

Deka Biosciences Closes USD $20M Series B2 Financing

September 28, 2023

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Al Iskandariyah John Mumm Viva Bioinnovator Detlev Biniszkiewicz Deka Biosciences Deka Biosciences Pre Filled Syringes

Source: finsmes.com

NextPoint Therapeutics Begins Immunotherapy Trial in Tumors Known to Express HHLA2

August 17, 2023

The firm is studying its KIR3DL3-targeted monoclonal antibody NPX267 in patients with metastatic solid tumors and conducting exploratory biomarker analysis.

United States Detlev Biniszkiewicz Nextpoint Therapeutics

Source: precisionmedicineonline.com

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science

Navigation

Detlev Biniszkiewicz News Today

Latest Updates of Viva's Portfolio Companies

Deka Biosciences Closes USD $20M Series B2 Financing

NextPoint Therapeutics Begins Immunotherapy Trial in Tumors Known to Express HHLA2

Explore More Categories